Relazione incarico aitini - allegato n°6 - pubblicazioni significative

Elenco Pubblicazioni in extenso di Enrico Aitini e Colleghi Struttura Complessa di Oncologia Medica ed Ematologia (autore, co-autore, principal investigator, main co-investigator) Franciosi V, Barbieri R, Aitini E et al: GEMCITABINE AND OXALIPLATIN: A SAFE AND ACTIVE REGIMEN IN POOR PROGNOSIS ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS. Lung Cancer. 2003 Jul;41(1):101-6 Gridelli C, Gallo C… Pari F, Aitini E et al: GEMCITABINE PLUS VINORELBINE COMPARED WITH CISPLATIN PLUS VINORELBINE OR CISPLATIN PLUS GEMCITABINE FOR ADVANCED NON-SMALL-CELL LUNG CANCER: A PHASE III TRIAL OF THE ITALIAN GEMVIN INVESTIGATORS AND THE NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP. J Clin Oncol. 2003 Aug Di Maio M, Perrone F… Pari F, Aitini E et al: SUPPORTIVE CARE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER. Br J Cancer. 2003 Sep 15;89(6):1013-21 The ATAC Trialist s’Group (among principal investigators: Aitini E, Cavazzini G) ANASTROZOLE ALONE OR IN COMBINATION WITH TAMOXIFEN VERSUS TAMOXIFEN ALONE FOR ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH EARLY-STAGE BREAST CANCER: RESULTS OF THE ATAC (ARIMIDEX, TAMOXIFEN ALONE OR IN COMBINATION) TRIAL EFFICACY AND SAFETY UPDATE ANALYSES. Cancer. 2003 Nov CantoreM, Fiorentini G…Zamagni D, Aitini E et al: RANDOMISED TRIAL OF GEMCITABINE VERSUS FLEC REGIMEN GIVEN INTRA-ARTERIALLY FOR PATIENTS WITH UNRESECTABLE PANCREATIC CANCER. J Exp Clin Cancer Res. 2003 Dec Guida M, Ravaioli A…Pari F, Aitini E .et al: FIBRINOGEN: A NOVEL PREDICTOR OF RESPONSIVENESS IN METASTATIC MELANOMA PATIENTS TREATED WITH BIO-CHEMOTHERAPY: IMI (ITALIAN MELANOMA INTER-GROUP) TRIAL. J Transl Med. 2003 Dec CantoreM, Fiorentini G…Zamagni, Rabbi C et al. MOLECULAR THERAPY: CLINICAL APPLICATIONS. INTRA-ARTERIAL ADENOVIRUSES ADMINISTRATION. J Exp Clin Cancer Res. 2003 Venturini M, Aitini E, Cavazzini G et al: DOSE-DENSE ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER PATIENTS: FIRST RESULTS FROM A RANDOMIZED TRIAL. Breast Cancer Res Treat, 2003 CantoreM, Fiorentini G…Zamagni D, Rabbi C et al. COMBINED IRINOTECAN AND OXALIPLATIN IN PATIENTS WITH ADVANCED PRE-TREATED PANCREATIC CANCER. Oncology. 2004 Intergroup Exemestane Study (among principal investigators: Aitini E) A RANDOMIZED TRIAL OF EXEMESTANE AFTER TWO TO THREE YEARS OF TAMOXIFEN THERAPY IN POSTMENOPAUSAL WOMEN WITH PRIMARY BREAST CANCER. N Engl J Med. 2004 Mar Labianca R, Fossati R, Zaniboni A (among principal investigators: Aitini E, Rabbi C) RANDOMIZED TRIAL OF INTRAPORTAL AND/OR SYSTEMIC ADJUVANT CHEMOTHERAPY IN PATIENTS WITH COLON CARCINOMA. J Natl Cancer Inst. 2004 May ON THE BANKS OF THE LIFE: I TUMORI GIOVANILI NELLA POESIA E NELLA LETTERATURA Tumori, May 2004 suppl. CantoreM, Rabbi C, Zamagni D, et al. GEMCITABINE VERSUS FLEC REGIMEN GIVEN INTRA-ARTERIALLY TO PATIENTS WITH UNRESECTABLE PANCREATIC CANCER: A PROSPECTIVE, RANDOMIZED PHASE III TRIAL OF THE ITALIAN SOCIETY FOR INTEGRATED LOCOREGIONAL THERAPY IN ONCOLOGY. J Chemother. 2004 Dec The ATAC Trialist s’Group (among principal investigators: Aitini E, Cavazzini G) RESULTS OF THE ATAC (ARIMIDEX, TAMOXIFEN, ALONE OR IN COMBINATION) TRIAL AFTER COMPLETION OF 5 YEARS' ADJUVANT TREATMENT FOR BREAST CANCER. Lancet. 2005 Jan Mambrini A,…Zamagni, Rabbi C et al. INTRA-ARTERIAL HEPATIC CHEMOTHERAPY IN HEAVILY PRETREATED PATIENTS WITH EPITHELIAL OVARIAN CANCER. Ann Oncol. 2005 Feb Louvet C, Labianca R… Aitini E et al: GEMCITABINE IN COMBINATION WITH OXALIPLATIN COMPARED WITH GEMCITABINE ALONE IN LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER: RESULTS OF A GERCOR AND GISCAD PHASE III TRIAL. J Clin Oncol. 2005 May 20;23(15):3509-16. Ardizzoni A, Favaretto A…Pari F et al: PLATINUM-ETOPOSIDE CHEMOTHERAPY IN ELDERLY PATIENTS WITH SMALL-CELL LUNG CANCER: RESULTS OF A RANDOMIZED MULTICENTER PHASE II STUDY ASSESSING ATTENUATED-DOSE OR FULL-DOSE WITH LENOGRASTIM PROPHYLAXIS--A FORZA OPERATIVA NAZIONALE ITALIANA CARCINOMA POLMONARE AND GRUPPO STUDIO TUMORI POLMONARI VENETO (FONICAP-GSTPV) STUDY. J Clin Oncol. 2005 Jan Piccart M et al (among principal investigators: Cavazzini G) TRANSTUZUMAB AFTER ADJUVANT CHEMOTHERAPY IN HER2-POSITIVE BREAST CANCER. The New England Journal of Medicine 333; 1659-1672. 2005 CantoreM, Mambrini A,…Zamagni, Rabbi C et al. PHASE II STUDY OF HEPATIC INTRAARTERIAL EPIRUBICIN AND CISPLATIN, WITH SYSTEMIC 5-FLUOROURACIL IN PATIENTS WITH UNRESECTABLE BILIARY TRACT TUMORS. Cancer. 2005 Apr Del Mastro L, Nicolò…. Cavazzini G, Aitini E et al: HER2 EXPRESSION AND EFFICACY OF DOSE-DENSE ANTHRACYCLINE-CONTAINING ADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS. Br J Cancer. 2005 Jul 11;93(1):7-14. Twelves C et al (among principal investigators: Rabbi C) CAPECITABINE AS ADJUVANT TREATMENT FOR STAGE III COLON CANCER. N Engl J Med. 2005 Jun Venturini M, Del Mastro L, Aitini E, Cavazzini G et al: DOSE-DENSE ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER PATIENTS: RESULTS FROM A RANDOMIZED TRIAL. J Natl Cancer Inst. 2005 Dec 7;97(23):1724-33. Aitini E, Aleotti P: BREAKING BAD NEWS IN ONCOLOGY: LIKE A WALK IN THE TWILIGHT? Aitini E, Cetto GL: A GOOD DEATH FOR CANCER PATIENTS: STILL A DREAM? Annals of Oncology, May 2006 The ATAC Trialist s’Group (among principal investigators: Aitini E, Cavazzini G) IMPACT OF CHEMOTHERAPY REGIMENS PRIOR TO ENDOCRINE THERAPY: RESULTS FROM THE ATAC (ANASTROZOLE AND TAMOXIFEN, ALONE OR IN COMBINATION) TRIAL. Cancer. 2006 Aug Di Bartolomeo M, Buzzoni R…Aitini E et al: FEASIBILITY OF SEQUENTIAL THERAPY WITH FOLFIRI FOLLOWED BY DOCETAXEL/CISPLATIN IN PATIENTS WITH RADICALLY RESECTED GASTRIC ADENOCARCINOMA. A RANDOMIZED PHASE III TRIAL. Oncology. 2006 The ATAC Trialist s’Group (among principal investigators: Aitini E, Cavazzini G) COMPREHENSIVE SIDE-EFFECT PROFILE OF ANASTROZOLE AND TAMOXIFEN AS ADJUVANT TREATMENT FOR EARLY-STAGE BREAST CANCER: LONG-TERM SAFETY ANALYSIS OF THE ATAC TRIAL. Lancet Oncology 2006; 7:633-43 Aitini E, Sempreboni A, Aleotti P, Zamagni D, Cavazzini G, Barbieri R, Cengarle R, Pari F, Rabbi C and Vivorio B: ANXIETY LEVELS IN CANCER PATIENTS AND "LIFE SOUND" EXPERIENCE. Tumori. 2007 Jan Bajetta E, Di Bartolomeo M…Aitini E .et al: URACIL/FTORAFUR/LEUCOVORIN COMBINED WITH IRINOTECAN (TEGAFIRI) OR OXALIPLATIN (TEGAFOX) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER PATIENTS: RESULTS OF RANDOMISED PHASE II STUDY. Br J Cancer. Feb 2007 Droghetti A, Schiavini A, …Aitini E .et al: CHEST WALL RECONSTRUCTION IN FULL-THICKNESS DEFECT FOR MASTECTOMY AND IRRADIATION. Ann Thorac Surg. Feb 2007 Bidoli P, Zilembo L…Aitini E, Pari F .et al: RANDOMIZED PHASE II THREE-ARM TRIAL WITH THREE PLATINUM-BASED DOUBLETS IN METASTATIC NON-SMALL-CELL LUNG CANCER. AN ITALIAN TRIALS IN MEDICAL ONCOLOGY STUDY. Ann Oncol. Mar 2007 Intergroup Exemestane Study (among principal investigators: Aitini E) SKELETAL EFFECTS OF EXEMESTANE ON BONE-MINERAL DENSITY, BONE BIOMARKERS, AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER PARTICIPATING IN THE INTERGROUP EXEMESTANE STUDY (IES): A RANDOMISED CONTROLLED STUDY. Lancet Oncol. 2007 Feb Intergroup Exemestane Study (among principal investigators: Aitini E) SURVIVAL AND SAFETY OF EXEMESTANE VERSUS TAMOXIFEN AFTER 2-3 YEARS' TAMOXIFEN TREATMENT (INTERGROUP EXEMESTANE STUDY): A RANDOMISED CONTROLLED TRIAL. Lancet. 2007 Feb Cascinu S, Labianca R… Aitini E, Rabbi C .et al: ADJUVANT TREATMENT OF HIGH-RISK, RADICALLY RESECTED GASTRIC CANCER PATIENTS WITH 5-FLUOROURACIL, LEUCOVORIN, CISPLATIN, AND EPIDOXORUBICIN IN A RANDOMIZED CONTROLLED TRIAL. J Natl Cancer Inst. 2007 Apr Del Mastro L, Dozin B, Aitini E…Cavazzini G et al: TIMING OF ADJUVANT CHEMOTHERAPY AND TAMOXIFEN IN WOMEN WITH BREAST CANCER: FINDINGS FROM TWO CONSECUTIVE TRIALS OF GRUPPO ONCOLOGICO NORD-OVEST MAMMELLA INTERGRUPPO (GONO MIG) GROUP. Ann Oncol. 2007 Oct Aitini E and Cavazzini G: DESIGN AND ARCHITECTURE IN ONCOLOGY AS SUPPORTIVE CARE FOR CANCER PATIENTS Tumori, Nov 2007 Pagani M, Antico A, Bellarosa S, Cavazzini G and Aitini E: PRIMARY PULMONARY HIGH GRADE NON-HODGKIN’S LYMPHOMA IN AN ELDERLY PATIENT. A CASE REPORT Tumori, Nov 2007 Galli L, Fontana A… Aitini E, Barbieri R et al: PHASE II STUDY OF SEQUENTIAL CHEMOTHERAPY WITH DOCETAXEL-ESTRAMUSTINE FOLLOWED BY MITOXANTRONE-PREDNISONE IN PATIENTS WITH ADVANCED HORMONE-REFRACTORY PROSTATE CANCER. Br J Cancer. 2007 Nov Cascinu S, Berardi R … Aitini E, .et al: CETUXIMAB PLUS GEMCITABINE AND CISPLATIN COMPARED WITH GEMCITABINE AND CISPLATIN ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER: A RANDOMISED, MULTICENTRE, PHASE II TRIAL. Lancet Oncol. 2007 Dec

Source: http://www.dipomantova.it/allegati/Relazione_incarico_Aitini-allegato6.pdf